Paul Boon

Paul Boon

Auto-generated profile, based on publicly available information

Paul Boon

Brain, Department of Head and Skin, Ghent University, Ghent, Belgium

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in The Lancet Neurology
Verified
Journal Article
Closed access
PRPhilippe Ryvlin
Philippe Ryvlin
LNLina Nashef
Lina Nashef
SLSamden D Lhatoo
Samden D Lhatoo
LBLisa M Bateman
Lisa M Bateman
JBJonathan Bird
Jonathan Bird
TTTorbjörn Tomson
Torbjörn Tomson

23 February 2010 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
HMH. Meierkord
H. Meierkord
PBP. Boon
P. Boon
BEB. Engelsen
B. Engelsen
KGK. Göcke
K. Göcke
SSS. Shorvon
S. Shorvon
MHM. Holtkamp
M. Holtkamp

1 October 2009 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
NBN.M.G. Bodde
N.M.G. Bodde
JBJ.L. Brooks
J.L. Brooks
GBG.A. Baker
G.A. Baker
PBP.A.J.M. Boon
P.A.J.M. Boon
JHJ.G.M. Hendriksen
J.G.M. Hendriksen
AAA.P. Aldenkamp
A.P. Aldenkamp

22 March 2007 in Epilepsia
Verified
Journal Article
Open access
PDF file
PBPaul Boon
Paul Boon
KVKristl Vonck
Kristl Vonck
VHVeerle De Herdt
Veerle De Herdt
ADAnnelies Van Dycke
Annelies Van Dycke
MGMaarten Goethals
Maarten Goethals
DRDirk Van Roost
Dirk Van Roost
Summary:  Purpose: This pilot study prospectively evaluated the efficacy of long‐term deep brain stimulation (DBS) in medial temporal lobe (MTL) structures in patients with MTL epilepsy. Methods: Twelve consecutive patients with refractory MTL epilepsy were included in this study. The protocol included invasive video‐EEG monitoring for ictal‐onset localization and evaluation for subsequent stimulation of the ictal‐onset zone. Side effects and changes in seizure frequency were carefully monitored. Results: Ten of 12 patients underwent long‐term MTL DBS. Two of 12 patients underwent selective amygdalohippocampectomy. After mean follow‐up of 31 months (range, 12–52 months), one of 10 stimulated patients are seizure free (>1 year), one of 10 patients had a >90% reduction in seizure frequency; five of 10 patients had a seizure‐frequency reduction of ≥50%; two of 10 patients had a seizure‐frequency reduction of 30–49%; and one of 10 patients was a nonresponder. None of the patients reported side effects. In one patient, MRI showed asymptomatic intracranial hemorrhages along the trajectory of the DBS electrodes. None of the patients showed changes in clinical neurological testing. Patients who underwent selective amygdalohippocampectomy are seizure‐free (>1 year), AEDs are unchanged, and no side effects have occurred. Conclusions: This open pilot study demonstrates the potential efficacy of long‐term DBS in MTL structures that should now be further confirmed by multicenter randomized controlled trials.

25 September 2002 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
KVKristl Vonck
Kristl Vonck
PBPaul Boon
Paul Boon
EAErik Achten
Erik Achten
JRJacques De Reuck
Jacques De Reuck
JCJacques Caemaert
Jacques Caemaert

1 January 2001 in The Lancet
Verified
Journal Article
Closed access
MQMichel Le Van Quyen
Michel Le Van Quyen
JMJacques Martinerie
Jacques Martinerie
VNVincent Navarro
Vincent Navarro
PBPaul Boon
Paul Boon
MDMichel D'HAvé
Michel D'HAvé
MBMichel Baulac
Michel Baulac